QUEST DIAGNOSTICS INC
DGXNYSETrading Snapshot
- Day Range
- β
- 52-Week Range
- $171.18 β $248.84
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 110.0M
- Next Earnings
- 2027-02-08
Fundamentals Snapshot
- Annual Revenue
- $11.04B
- Last Q Revenue
- $3.10B
- P/E Ratio
- 23.8
- P/S Ratio
- 2.3x
- EPS (TTM)
- $10.06
- Dividend Yield
- 1.37%
- Dilution (1yr)
- β0.9%
QUEST DIAGNOSTICS INC
DGXAbout QUEST DIAGNOSTICS INC
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Latest News & Updates
News unavailable.